Differentiation of melanoma and benign nevi by fluorescence in-situ hybridization

Melanoma Research

Volumn 21, Issue 5, 2011, Pages 426-430

  Hossain, Deloar ^a   Qian, Junqi ^a   Adupe, Joy ^a   Drewnowska, Krystyna ^a   Bostwick, David G ^a  

^a BOSTWICK LABORATORIES   (United States)

Author keywords

chromosome; diagnosis; DNA; fluorescence in situ hybridization; melanoma; nevus; pathology

Indexed keywords

ADULT; AGED; ARTICLE; CELL COUNT; CHROMOSOME 11; CHROMOSOME 20; CHROMOSOME 6; CHROMOSOME 7; CHROMOSOME ABERRATION; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DNA PROBE; EPIDERMIS; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MELANOMA; MELANOMA CELL; NEVUS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; SKIN BIOPSY; TISSUE SECTION;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MELANOMA; MIDDLE AGED; NEVUS; SKIN NEOPLASMS; YOUNG ADULT;

EID: 80052655057     PISSN: 09608931     EISSN: 14735636     Source Type: Journal    
DOI: 10.1097/CMR.0b013e328347ee1d     Document Type: Article

References (36)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59:225-249.
2. Bosbous MW, Dzwierzynski WW, Neuburg M. Staged excision of lentigo maligna and lentigo maligna melanoma: A 10-year experience. Plast Reconstr Surg 2009; 124:1947-1955.
3. Moreno MA, Hanna EY. Management of mucosal melanomas of the head and neck: Did we make any progress. Curr Opin Otolaryngol Head Neck Surg 2010; 18:101-106.
4. Sladden MJ, Balch C, Barzilai DA, Berg D, Freiman A, Handiside T, et al. Surgical excision margins for primary cutaneous melanoma. Cochrane Database Syst Rev 2009;CD004835.
5. Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, et al. Final version of 2009 ajcc melanoma staging and classification. J Clin Oncol 2009; 27:6199-6206.
6. Eigentler TK, Garbe C. Malignant melanoma: Classification and staging of malignant melanoma. Front Radiat Ther Oncol 2006; 39:149-158. (Pubitemid 43264878)
7. Forman SB, Ferringer TC, Peckham SJ, Dalton SR, Sasaki GT, Libow LF, et al. Is superficial spreading melanoma still the most common form of malignant melanoma? J Am Acad Dermatol 2008; 58:1013-1020. (Pubitemid 351657607)
8. Scolyer RA, Thompson JF, Stretch JR, Sharma R, McCarthy SW. Pathology of melanocytic lesions: New, controversial, and clinically important issues. J Surg Oncol 2004; 86:200-211. (Pubitemid 38880287)
9. Smoller BR. Histologic criteria for diagnosing primary cutaneous malignant melanoma. Mod Pathol 2006; 19(Suppl 2):S34-S40. (Pubitemid 43172308)
10. Krieger N, Hiatt RA, Sagebiel RW, Clark WH Jr., Mihm MC Jr. Inter-observer variability among pathologists' evaluation of malignant melanoma: Effects upon an analytic study. J Clin Epidemiol 1994; 47:897-902. (Pubitemid 24268894)
11. Lock-Andersen J, Hou-Jensen K, Hansen JP, Jensen NK, Sogaard H, Andersen PK. Observer variation in histological classification of cutaneous malignant melanoma. Scand J Plast Reconstr Surg Hand Surg 1995; 29:141-148.
12. Brochez L, Verhaeghe E, Grosshans E, Haneke E, Pierard G, Ruiter D, et al. Inter-observer variation in the histopathological diagnosis of clinically suspicious pigmented skin lesions. J Pathol 2002; 196:459-466. (Pubitemid 34262859)
13. Clemente C, Bettio D, Venci A, Scopsi L, Rao S, Ferrari A, et al. A fluorescence in situ hybridization (fish) procedure to assist in differentiating benign from malignant melanocytic lesions. Pathologica 2009; 101:169-174.
14. Dalton SR, Gerami P, Kolaitis NA, Charzan S, Werling R, LeBoit PE, et al. Use of fluorescence in situ hybridization (fish) to distinguish intranodal nevus from metastatic melanoma. Am J Surg Pathol 2010; 34:231-237.
15. Gerami P, Jewell SS, Morrison LE, Blondin B, Schulz J, Ruffalo T, et al. Fluorescence in situ hybridization (fish) as an ancillary diagnostic tool in the diagnosis of melanoma. Am J Surg Pathol 2009; 33:1146-1156.
16. Morey AL, Murali R, McCarthy SW, Mann GJ, Scolyer RA. Diagnosis of cutaneous melanocytic tumours by four-colour fluorescence in situ hybridisation. Pathology 2009; 41:383-387.
17. Newman MD, Lertsburapa T, Mirzabeigi M, Mafee M, Guitart J, Gerami P. Fluorescence in situ hybridization as a tool for microstaging in malignant melanoma. Mod Pathol 2009; 22:989-995.
18. Balazs M, Adam Z, Treszl A, Begany A, Hunyadi J, Adany R. Chromosomal imbalances in primary and metastatic melanomas revealed by comparative genomic hybridization. Cytometry 2001; 46:222-232. (Pubitemid 32899792)
19. Bauer J, Bastian BC. Distinguishing melanocytic nevi from melanoma by DNA copy number changes: Comparative genomic hybridization as a research and diagnostic tool. Dermatol Ther 2006; 19:40-49.
20. Mensink HW, Kilic E, Vaarwater J, Douben H, Paridaens D, de Klein A. Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome. Cancer Genet Cytogenet 2008; 181:108-111. (Pubitemid 351273423)
21. Speicher MR, Prescher G, du Manoir S, Jauch A, Horsthemke B, Bornfeld N, et al. Chromosomal gains and losses in uveal melanomas detected by comparative genomic hybridization. Cancer Res 1994; 54:3817-3823. (Pubitemid 24241201)
22. Trolet J, Hupe P, Huon I, Lebigot I, Decraene C, Delattre O, et al. Genomic profiling and identification of high-risk uveal melanoma by array cgh analysis of primary tumors and liver metastases. Invest Ophthalmol Vis Sci 2009; 50:2572-2580.
23. Vanison C, Tanna N, Murthy AS. Comparative genomic hybridization for the diagnosis of melanoma. Eur J Plast Surg 2010; 33:45-48.
24. Newman MD, Mirzabeigi M, Gerami P. Chromosomal copy number changes supporting the classification of lentiginous junctional melanoma of the elderly as a subtype of melanoma. Mod Pathol 2009; 22: 1258-1262.
25. Pouryazdanparast P, Newman M, Mafee M, Haghighat Z, Guitart J, Gerami P. Distinguishing epithelioid blue nevus from blue nevus-like cutaneous melanoma metastasis using fluorescence in situ hybridization. Am J Surg Pathol 2009; 33:1396-1400.
26. Gerami P, Mafee M, Lurtsbarapa T, Guitart J, Haghighat Z, Newman M. Sensitivity of fluorescence in situ hybridization for melanoma diagnosis using rreb1, myb, cep6, and 11q13 probes in melanoma subtypes. Arch Dermatol 2010; 146:273-278.
27. Bradley S, Zamechek L, Aurich-Costa J. Oligonucleotide fish probes; In: liehr T, ed. Flourescence in situ hybridization (fish)-application uide, Springer, 2009, Vol 1, pp 67-73. Heidelberg, Germany. www.springlink.com
28. Greshock J, Nathanson K, Medina A, Ward MR, Herlyn M, Weber BL, et al. Distinct patterns of DNA copy number alterations associate with braf mutations in melanomas and melanoma-derived cell lines. Genes Chromosomes Cancer 2009; 48:419-428.
29. Laud K, Kannengiesser C, Avril MF, Chompret A, Stoppa-Lyonnet D, Desjardins L, et al. Braf as a melanoma susceptibility candidate gene? Cancer Res 2003; 63:3061-3065. (Pubitemid 36735852)
30. Lazar V, Ecsedi S, Szollosi AG, Toth R, Vizkeleti L, Rakosy Z, et al. Characterization of candidate gene copy number alterations in the 11q13 region along with braf and nras mutations in human melanoma. Mod Pathol 2009; 22:1367-1378.
31. Moore SR, Persons DL, Sosman JA, Bobadilla D, Bedell V, Smith DD, et al. Slovak ML: Detection of copy number alterations in metastatic melanoma by a DNA fluorescence in situ hybridization probe panel and array comparative genomic hybridization: A southwest oncology group study (s9431). Clin Cancer Res 2008; 14:2927-2935.
32. Muthusamy V, Hobbs C, Nogueira C, Cordon-Cardo C, McKee PH, Chin L, et al. Amplification of cdk4 and mdm2 in malignant melanoma. Genes Chromosomes Cancer 2006; 45:447-454.
33. Utikal J, Udart M, Leiter U, Peter RU, Krahn G. Additional cyclin d(1) gene copies associated with chromosome 11 aberrations in cutaneous malignant melanoma. Int J Oncol 2005; 26:597-605.
34. Mallikarjuna K, Pushparaj V, Biswas J, Krishnakumar S. Expression of epidermal growth factor receptor, ezrin, hepatocyte growth factor, and c-met in uveal melanoma: An immunohistochemical study. Curr Eye Res 2007; 32:281-290. (Pubitemid 46439685)
35. Topcu-Yilmaz P, Kiratli H, Saglam A, Soylemezoglu F, Hascelik G.: Correlation of clinicopathological parameters with hgf, c-met, egfr, and igf-1r expression in uveal melanoma. Melanoma Res 2010; 20:126-132.
36. Koynova DK, Jordanova ES, Milev AD, Dijkman R, Kirov KS, Toncheva DI, et al. Gene-specific fluorescence in-situ hybridization analysis on tissue microarray to refine the region of chromosome 20q amplification in melanoma. Melanoma Res 2007; 17:37-41. (Pubitemid 46145478)